Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
E. Chris Muly, MD, PhD: Signal Transduction Abnormalities in Schizophrenia: the cAMP System
1
x
$
30.00
Marcia L. Verduin, MD: Psychosis and Delirium Following Metabolife Use
1
x
$
30.00
Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
1
x
$
30.00
Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
1
x
$
30.00
Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis
1
x
$
30.00
Branimir Margetic: A Case of Stuttering During Treatment with Levomepromazine
1
x
$
30.00
La guía 2016 sobre interacciones entre medicamentos psicotrópicos, Part 1
1
x
$
15.00
Gregory M. Asnis, MD: IFN-Induced Depression: A Role for NSAIDs
1
x
$
30.00
Duloxetine in Military Posttraumatic Stress Disorder
1
x
$
30.00
Gender and Schizophrenia
1
x
$
30.00
A Comprehensive Monitoring of Clozapine and Related Components in Clinical Practices. Saudi Arabian Scenario
1
x
$
30.00
View Cart
Checkout
Home
Store
“A Comprehensive Monitoring of Clozapine and Related Components in Clinical Practices. Saudi Arabian Scenario” has been added to your cart.
View cart
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Adult ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist
$
0.00
Add to cart
Details
Advances in Recognition and Treatment of Social Anxiety Disorder: A 10-Year Retrospective
$
30.00
Add to cart
Details
Advancing the Treatment of Anxiety Disorders: New Findings and Novel Uses for Atypical Antipsychotics
$
30.00
Add to cart
Details
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
$
30.00
Add to cart
Details
Adverse Effects of Recreational and Medical Cannabis
$
30.00
Add to cart
Details
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
$
30.00
Add to cart
Details
Agomelatine Monotherapy for Autism—A Case Report
$
30.00
Add to cart
Details
Ahmad Ghanizadeh – Can Fluoxetine Alone Cause Serotonin Syndrome in Adolescents?
$
30.00
Add to cart
Details
Ahmad Ghanizadeh – Does Risperidone Improve Hyperacusia in Children with Autism?
$
30.00
Add to cart
Details
Ahmad Ghanizadeh, MD: Photophobia and Methylphenidate
$
30.00
Add to cart
Details
Akathisia Induced by Abrupt Withdrawal of Risperidone: A Case Report
$
30.00
Add to cart
Details
Akinetic Mutism Following Bilateral Infarcts Associated with a Mitral Valve Papillary Fibroelastoma
$
30.00
Add to cart
Details
Alexander Neumeister, MD: Tryptophan Depletion, Serotonin, and Depression: Where Do We Stand?
$
30.00
Add to cart
Details
Algorithms in Clinical Psychiatry: A Stepped Approach Toward the Path to Recovery
$
30.00
Add to cart
Details
Aligerando la carga: la depresión en Latinoamérica
$
0.00
Add to cart
Details
Alisa B. Busch – Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing
$
30.00
Add to cart
Details
Aliza P. Wingo – Frequency of Stimulant Treatment and of Stimulant-Associated Mania/Hypomania in Bipolar Disorder Patients
$
30.00
Add to cart
Details
Alzheimer’s and Dementia Guidelines and Tables
$
30.00
Add to cart
Details
Amisulpride for Clozapine Induced Sialorrhea
$
30.00
Add to cart
Details
Amy M. Kilbourne, PhD, MPH: Determinants of Complementary and Alternative Medicine Use by Patients with Bipolar Disorder
$
30.00
Add to cart
Details
Previous
1
2
3
4
…
44
Next
Page load link
Go to Top
